These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 11979914)

  • 21. Bone turnover in untreated polymyalgia rheumatica.
    Barnes TC; Daroszewska A; Fraser WD; Bucknall RC
    Rheumatology (Oxford); 2004 Apr; 43(4):486-90. PubMed ID: 14722347
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of male osteoporosis].
    Iba K
    Nihon Rinsho; 2002 Mar; 60 Suppl 3():306-14. PubMed ID: 11979923
    [No Abstract]   [Full Text] [Related]  

  • 23. The use of biochemical markers in osteoporosis.
    Hammett-Stabler CA
    Clin Lab Med; 2004 Mar; 24(1):175-97. PubMed ID: 15157562
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Markers of bone resorption predict hip fracture in elderly women: the EPIDOS Prospective Study.
    Garnero P; Hausherr E; Chapuy MC; Marcelli C; Grandjean H; Muller C; Cormier C; Bréart G; Meunier PJ; Delmas PD
    J Bone Miner Res; 1996 Oct; 11(10):1531-8. PubMed ID: 8889854
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of four biochemical markers of bone metabolism in postmenopausal osteoporosis.
    Majkić-Singh N; Ilić M; Ignjatović S; Aleksandra-Postić-Grujin
    Clin Lab; 2002; 48(7-8):407-13. PubMed ID: 12146575
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early changes in biochemical markers of bone formation predict BMD response to teriparatide in postmenopausal women with osteoporosis.
    Chen P; Satterwhite JH; Licata AA; Lewiecki EM; Sipos AA; Misurski DM; Wagman RB
    J Bone Miner Res; 2005 Jun; 20(6):962-70. PubMed ID: 15883636
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis.
    Garnero P; Sornay-Rendu E; Chapuy MC; Delmas PD
    J Bone Miner Res; 1996 Mar; 11(3):337-49. PubMed ID: 8852944
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monitoring of Risedronate by biochemical bone markers in clinical practice.
    Bunyaratavej N
    J Med Assoc Thai; 2005 Oct; 88(suppl 5):S34-6. PubMed ID: 17500121
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biochemical markers of bone turnover for the clinical assessment of bone metabolism.
    Taylor AK; Lueken SA; Libanati C; Baylink DJ
    Rheum Dis Clin North Am; 1994 Aug; 20(3):589-607. PubMed ID: 7984780
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Bone and bone related biochemical examinations. Bone and collagen related metabolites. Measurement of PICP and PINP in the evaluation of pharmaceutical treatment efficacy for osteoporosis].
    Nakatsuka K; Nishizawa Y; Miura M
    Clin Calcium; 2006 Jun; 16(6):977-85. PubMed ID: 16751694
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Can biochemical markers for bone density be recommended as diagnostic and prognostic tools in osteoporosis?].
    Midtby M; Magnus JH
    Tidsskr Nor Laegeforen; 1998 Feb; 118(4):575-9. PubMed ID: 9520586
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Markers of bone turnover: consideration on their clinical application in osteoporosis.
    Cantatore FP; Pipitone V
    Panminerva Med; 1999 Sep; 41(3):247-51. PubMed ID: 10568124
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Osteoporosis-profile--a bad examination?].
    Sørensen OH; Nielsen SP; Thode J; Eriksen EF
    Ugeskr Laeger; 1994 Sep; 156(38):5503-5. PubMed ID: 7941083
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biochemical markers of bone turnover: an update.
    van Daele PL; Birkenhäger JC; Pols HA
    Neth J Med; 1994 Feb; 44(2):65-72. PubMed ID: 8208326
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The use of bone markers in a 6-week study to assess the efficacy of oral clodronate in patients with metastatic bone disease.
    Brown JE; McCloskey EV; Dewar JA; Body JJ; Cameron DA; Harnett AN; Ruutu M; Purohit OP; Tähtelä R; Coleman RE
    Calcif Tissue Int; 2007 Nov; 81(5):341-51. PubMed ID: 17874331
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discriminative value of biochemical markers of bone turnover in assessing the activity of Paget's disease.
    Alvarez L; Guañabens N; Peris P; Monegal A; Bedini JL; Deulofeu R; Martinez de Osaba MJ; Muñoz-Gomez J; Rivera-Fillat F; Ballesta AM
    J Bone Miner Res; 1995 Mar; 10(3):458-65. PubMed ID: 7785468
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bone markers in osteoporosis and malignancy.
    Lipton A; Costa L; Demers LM
    Can J Oncol; 1995 Dec; 5 Suppl 1():11-5. PubMed ID: 8853519
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Serum PINP(N-terminal propeptide of type I procollagen)].
    Ueda M; Inaba M
    Nihon Rinsho; 2004 Feb; 62 Suppl 2():373-7. PubMed ID: 15035155
    [No Abstract]   [Full Text] [Related]  

  • 39. The efficacy of the bone markers osteocalcin and the carboxyterminal cross-linked telopeptide of type-I collagen in evaluating osteogenesis in a canine crural lengthening model.
    Theyse LF; Mol JA; Voorhout G; Terlou M; Hazewinkel HA
    Vet J; 2006 May; 171(3):525-31. PubMed ID: 16624720
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [N-terminal crosslinking telopeptide of type I collagen].
    Fukunaga M
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():236-9. PubMed ID: 15658308
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.